Sep 15, 2020 / 03:00PM GMT
Boobalan Pachaiyappan - H.C. Wainwright - Equity Research Associate
Hello, again. Our next presenter is Bruce Steel, who is the Co-Founder, Director, President, and CEO of Equillium, Inc. Equillium is focused on developing drugs to address unmet needs in immunoinflammatory disorders. Please join me in welcoming Bruce.
Bruce Steel - Equillium, Inc. - CEO
Good morning, Boobalan, and thank you very much. I'm very pleased to present Equillium to you this morning. I hope everybody is doing well despite the ongoing pandemic. A quick slide of our forward-looking statements.
I'm very pleased to provide some updates today. We actually had a press release this morning that I'll cover here in a moment. But in terms of an introduction for those of you who are new to the Equillium story, we aspire to build a world-class biotechnology company focused on improving the lives of patients suffering from severe immunoinflammatory disorders. We are developing itolizumab, EQ001, which is a first-in-class antibody therapeutic for the treatment of a range of autoimmune and
Equillium Inc at Rodman & Renshaw Global Investment Conference Sponsored by H C Wainwright Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers